Challenging year for Sun Pharma in US as FY26 revenue falls 0.9%

Sun Pharma’s FY26 US revenue declines 0.9 per cent amid continued pressure in generics business despite growth in innovative medicines and specialty portfolio

Source :- Companies Read More

Share it :

Leave a Reply Cancel reply

Get free tips and resources right in your inbox, along with 10,000+ others

Latest Post

Korean investors dump home stocks for US, buying same names at a premium | Is Wall Street headed for KOSPI-style crash?

August 19, 2026

HEG receives NCLT approval for demerger scheme; shareholders to get 1:1 shares in HEG Graphite

August 19, 2026

Ahead of Market: 10 things that will decide stock market action on Thursday

August 19, 2026

Estee Lauder bets on fragrances and skincare to deliver strong annual profit

August 19, 2026

US dollar falls to lowest level since late May after Treasury doubles bond buybacks

August 19, 2026

Sebi bars two entities from markets over manipulation in CAS, orders ₹3.68 crore disgorgement

August 19, 2026

Challenging year for Sun Pharma in US as FY26 revenue falls 0.9%

Leave a Reply Cancel reply

Get free tips and resources right in your inbox, along with 10,000+ others

Categories

Latest Post

Categories

Useful Link

Company